Literature DB >> 20718901

Oral ivermectin for head lice: a comparison with 0.5 % topical malathion lotion.

Ahmad Nofal1.   

Abstract

BACKGROUND: Reports of treatment failure of head lice have become increasingly common. Oral ivermectin has been proposed as a potential alternative for the treatment of head lice infestation. The aim of this study was to compare the efficacy of oral ivermectin with topical malathion lotion in the treatment of head lice. PATIENTS AND METHODS: Eighty apparently healthy children with head lice infestation were randomly assigned to 2 groups, with 40 patients in each. The first group received oral ivermectin as a single dose of 200 μg/kg and the second group received single topical application of malathion lotion 0.5%. Follow up visits were done at days 8, 15 and 29. A second dose of either drug was given at day 8 in case of treatment failure.
RESULTS: After a single dose, complete cure was achieved in 77.5% and 87.5% of ivermectin and malathion groups respectively. After the second dose for nonresponders, the cure rate increased to 92.5% in the ivermectin group and 95% in the malathion group. No major adverse effects were observed in either group.
CONCLUSIONS: Oral ivermectin is a promising effective approach for the treatment of head lice and could be an ideal substitute for conventional pediculicides.
© The Author • Journal compilation © Blackwell Verlag GmbH, Berlin.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20718901     DOI: 10.1111/j.1610-0387.2010.07487.x

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


  9 in total

Review 1.  Head Lice.

Authors:  Laura Meister; Falk Ochsendorf
Journal:  Dtsch Arztebl Int       Date:  2016-11-11       Impact factor: 5.594

Review 2.  Paediatrics: how to manage pediculosis capitis.

Authors:  Alexander K C Leung; Joseph M Lam; Kin Fon Leong; Benjamin Barankin; Kam Lun Hon
Journal:  Drugs Context       Date:  2022-03-14

Review 3.  Broadening the range of use cases for ivermectin - a review of the evidence.

Authors:  Christian Kositz; John Bradley; Harry Hutchins; Anna Last; Umberto D'Alessandro; Michael Marks
Journal:  Trans R Soc Trop Med Hyg       Date:  2022-03-02       Impact factor: 2.455

Review 4.  Treatment of Pediculosis Capitis.

Authors:  Prashant Verma; Chaitanya Namdeo
Journal:  Indian J Dermatol       Date:  2015 May-Jun       Impact factor: 1.494

Review 5.  Management and Treatment of Human Lice.

Authors:  Abdoul Karim Sangaré; Ogobara K Doumbo; Didier Raoult
Journal:  Biomed Res Int       Date:  2016-07-27       Impact factor: 3.411

6.  Pediculosis capitis in Abidjan, Côte d'Ivoire: Epidemiological profile and associated risk factors.

Authors:  V Djohan; K E Angora; S Miezan; A K Bédia; A Konaté; A H Vanga-Bosson; F K Kassi; Pcm Kiki-Barro; W Yavo; E I Menan
Journal:  Parasite Epidemiol Control       Date:  2020-06-20

7.  Treatment of childhood phthiriasis palpebrarum with systemic ivermectin.

Authors:  Ibrahim Fouda; Ahmad Nofal; Mohamed M Fawzy; Fatma Eldeeb
Journal:  JAAD Case Rep       Date:  2021-06-03

8.  Impact of ivermectin administered for scabies treatment on the prevalence of head lice in Atoifi, Solomon Islands.

Authors:  Suny Coscione; Tommy Esau; Esau Kekeubata; Jason Diau; Rowena Asugeni; David MacLaren; Andrew C Steer; Christian Kositz; Michael Marks
Journal:  PLoS Negl Trop Dis       Date:  2018-09-25

9.  Prevalence and Alternative Treatment of Head-Lice Infestation in Rural Thailand: A Community-Based Study.

Authors:  On-Uma Singhasivanon; Saranath Lawpoolsri; Mathirut Mungthin; Surapon Yimsamran; Ngamphol Soonthornworasiri; Srivicha Krudsood
Journal:  Korean J Parasitol       Date:  2019-10-31       Impact factor: 1.341

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.